Phase I Study of Concomitant Gemcitabine and IMRT for Patients with Unresectable Adenocarcinoma of the Pancreatic Head

International Journal of Pancreatology - Tập 30 Số 3 - Trang 123-132
Christopher H. Crane1, John A. Antolak2, Isaac I. Rosen2, Kenneth Forster2, Douglas B. Evans3, Nora A. Janjan1, Chusilp Charnsangavej4, Peter W.T. Pisters3, Renato Lenzi5, Micheal A. Papagikos1, Robert A. Wolff5
1Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA
2Department of Radiation Physics, The University of Texas M.D. Anderson Cancer Center, Houston, USA
3Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA
4Department of Diagnostic Radiology, Pancreatic Tumor Study Group, The University of Texas M.D. Anderson Cancer Center, Houston, USA
5Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

International Journal of Pancreatology

Tập 30 Số 3

123-132

Thông tin tác giả